FDA Committee discusses Pfizer COVID-19 vaccine Emergency Use Authorization request

Vaccines and Related Biological Products Advisory Committee – 6/15/2022Подробнее

FDA Postpones Review of Vaccines for Young Kids: More Data Coming InПодробнее

Vaccines and Related Biological Products Advisory Committee – 6/7/2022Подробнее

FDA to discuss Pfizer COVID-19 vaccine approval for kids ages 5-11Подробнее

Vaccines and Related Biological Products Advisory Committee – 6/10/2021Подробнее

Additional mRNA COVID-19 Vaccine for Moderately to Severely Immunocompromised PeopleПодробнее

FDA panel to discuss approval of Pfizer COVID-19 vaccine for kids ages 5-11Подробнее

On FDA's Urging Pfizer-BionTech Applies for Vaccine Authorization for Under 5 YearsПодробнее

Vaccines and Related Biological Products Advisory Committee – 6/14/2022Подробнее

Vaccines and Related Biological Products Advisory Committee – 10/26/2021Подробнее

CDC committee meets to discuss allocating COVID-19 vaccine following the FDA's Pfizer approvalПодробнее

FDA COVID-19 Vaccines Advisory Committee Meeting for Emergency Use AuthorizationПодробнее

Vaccines and Related Biological Products Advisory Committee - 12/17/2020Подробнее

Vaccines and Related Biological Products Advisory Committee – 2/26/2021Подробнее

FDA announces advisory committee meeting to discuss Pfizer’s COVID-19 vaccine approvalПодробнее

Vaccines and Related Biological Products Advisory Committee - 12/10/2020Подробнее

Coronavirus Vaccine Update With Arnold S. Monto, MDПодробнее

FDA panel reviews Pfizer's COVID-19 vaccine for emergency use authorizationПодробнее

FDA COVID-19 Vaccines Advisory Committee Meeting for Emergency Use AuthorizationПодробнее